Neutralizing antiviral antibodies reduce hematogenic viral spread but not antiviral cytotoxic T cell induction and subsequent immunopathology.
Battegay
M
M
Seiler
P
P
Hunziker
L
L
Wolf
K
K
Zinkernagel
R M
RM
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000914:Antibodies, Viral / Q000276:immunology*; D004195:Disease Models, Animal; D007116:Immunization, Passive; D008216:Lymphocytic Choriomeningitis / Q000276:immunology / Q000628:therapy* / Q000821:virology; D008217:Lymphocytic choriomeningitis virus / Q000276:immunology; D051379:Mice; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
D000911:Antibodies, Monoclonal; D000914:Antibodies, Viral